Literature DB >> 12615201

Akt is TCL-ish: implications for B-cell lymphoma.

Michael R Gold1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615201     DOI: 10.1016/s1471-4906(03)00022-x

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


× No keyword cloud information.
  6 in total

1.  Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1.

Authors:  Queenie Lai Kwan Lam; Shengjun Wang; Otis King Hung Ko; Paul W Kincade; Liwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Akt fine-tunes NF-κB-dependent gene expression during T cell activation.

Authors:  Jing Cheng; Binh Phong; David C Wilson; Raphael Hirsch; Lawrence P Kane
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

3.  Interaction between TCL1 and Epac1 in the activation of Akt kinases in plasma membranes and nuclei of 8-CPT-2-O-Me-cAMP-stimulated macrophages.

Authors:  Uma K Misra; Steven J Kaczowka; Salvatore V Pizzo
Journal:  Cell Signal       Date:  2007-10-12       Impact factor: 4.315

4.  The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: Gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-O-Me-cAMP activation of Akt activity in macrophages.

Authors:  Uma K Misra; Steven Kaczowka; Salvatore V Pizzo
Journal:  Cell Signal       Date:  2008-04-15       Impact factor: 4.315

5.  Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.

Authors:  D Kern; G Regl; S W Hofbauer; P Altenhofer; G Achatz; A Dlugosz; H Schnidar; R Greil; T N Hartmann; F Aberger
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

6.  Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo.

Authors:  M Hashimoto; F Suizu; W Tokuyama; H Noguchi; N Hirata; M Matsuda-Lennikov; T Edamura; M Masuzawa; N Gotoh; S Tanaka; M Noguchi
Journal:  Oncogenesis       Date:  2013-09-16       Impact factor: 7.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.